Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
The Journal of Antimicrobial Chemotherapy|December 6, 2001
Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failureM Valtonen, E Tiula, O Takkunen, et al.
European Journal of Clinical Pharmacology|May 20, 1998
The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicinJ T Backman, K T Kivistö, K T Olkkola, et al.
British Journal of Clinical Pharmacology|January 5, 2006
Effect of rifampicin on the pharmacokinetics of pioglitazoneTiina Jaakkola, Janne T Backman, Mikko Neuvonen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 31, 2000
Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 usersT Backman, S Huhtala, T Blom, et al.
Plos One|April 27, 2019
Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic reviewLaura S M Kuula, Kati M Viljemaa, Janne T Backman, et al.
European Journal of Clinical Pharmacology|June 10, 2011
No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acidXiaoqiang Xiang, Juha Vakkilainen, Janne T Backman, et al.
Clinical Pharmacology and Therapeutics|December 1, 1999
Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisaprideK T Kivistö, J J Lilja, J T Backman, et al.
European Journal of Clinical Pharmacology|January 11, 2001
Effects of metronidazole on midazolam metabolism in vitro and in vivoJ S Wang, J T Backman, K T Kivistö, et al.
Pharmacogenetics and Genomics|November 16, 2012
SLCO2B1 c.935G>A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskirenTuija Tapaninen, Tiina Karonen, Janne T Backman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectivelyXia Wen, Jun-Sheng Wang, Janne T Backman, et al.
Pageof 23